Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spatial and temporal tracking of multi-layered cells sheet using reporter gene imaging with human sodium iodide symporter: a preclinical study using a rat model of myocardial infarction.

European journal of nuclear medicine and molecular imaging·2024

Same author

Predictive Value of PERCIST for Locally Advanced Non-Small Cell Lung Cancer Treated with Preoperative Induction Therapy - A Multicenter Study in Japan.

Cancer management and research·2024

Same author

A Luciferase Reporter Assay to Detect Cellular Hypoxia In Vitro.

Methods in molecular biology (Clifton, N.J.)·2024

Same author

Radionuclide Reporter Imaging to Visualize Tumor Hypoxia Ex Vivo and In Vivo.

Methods in molecular biology (Clifton, N.J.)·2024

Same author

Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer.

Cancer diagnosis & prognosis·2023

Same author

[Impact of Residual Radioactivity Rate of <sup>99m</sup>Tc-macro Aggregated Albumin (MAA) in Syringes and Administration Routes with a Focus on Pediatric Nuclear Medicine Examinations].

Nihon Hoshasen Gijutsu Gakkai zasshi·2023

Search research articles

Related Experiment Video

Updated: Apr 24, 2026

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Published on: October 25, 2024

[Oncology PET imaging].

Masayuki Inubushi

Igaku Butsuri : Nihon Igaku Butsuri Gakkai Kikanshi = Japanese Journal of Medical Physics : an Official Journal of Japan Society of Medical Physics

|September 10, 2014

Summary

This summary is machine-generated.

This article explains Positron Emission Tomography/Computed Tomography (PET/CT) imaging in oncology, detailing its current use in Japan and future prospects for targeted cancer therapies.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

Related Experiment Videos

Last Updated: Apr 24, 2026

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Published on: October 25, 2024

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

Area of Science:

Nuclear Medicine
Radiology
Oncology

Background:

Medical imaging, particularly PET/CT, plays a crucial role in cancer diagnosis.
Understanding the diagnostic process and limitations of imaging modalities is vital for medical physics specialists.
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is the predominant form of PET imaging in clinical oncology in Japan.

Purpose of the Study:

To elucidate the diagnostic process and challenges in PET/CT imaging.
To provide a comprehensive overview of current FDG-PET imaging in oncology in Japan, including coverage, significance, principles, protocols, and pitfalls.
To envision the future of oncology PET, focusing on cancer-specific applications for evaluating novel molecular targeted drugs.

Main Methods:

Review and synthesis of current practices and literature regarding PET/CT and FDG-PET imaging in oncology.
Explanation of the fundamental principles and clinical utility of FDG-PET.
Discussion of practical aspects such as health insurance coverage and common pitfalls in Japan.

Main Results:

FDG-PET imaging constitutes over 99% of all clinical PET examinations in Japan for oncological purposes.
The article details the essential components of FDG-PET imaging, from basic principles to clinical application challenges.
Current limitations and future potential for advanced PET applications are highlighted.

Conclusions:

PET/CT imaging is a critical tool in oncology, with FDG-PET being the standard in Japan.
Further development towards cancer-specific PET tracers is essential for assessing emerging targeted therapies.
The future of oncology PET lies in its ability to precisely evaluate treatment response for molecularly targeted drugs.